Biotechnology

Countdown to SLAS Europe: NestEgg Labs BV
  1. Biotechnology

Countdown to SLAS Europe: NestEgg Labs BV

Founded in 2022 by Tanner Carden (CEO) and Hans Keijdener, Maastricht-based start-up NestEgg Labs BV focuses on developing interoperable automation systems for cell culture that reduce manual intervention, improve workflow reproducibility, and limit plastics waste. At the core of NestEgg’s offering is Ovation, a smart incubator platform designed to automate key stages of the cell […]
Written by
Detecting Radiation Esophagitis Using 18F-FAPI-04 PET
  1. Biotechnology

Detecting Radiation Esophagitis Using 18F-FAPI-04 PET

In a groundbreaking development in oncology imaging, researchers have unveiled the potential of a novel positron emission tomography/computed tomography (PET/CT) tracer, ^18F-FAPI-04, to sensitively detect radiation esophagitis (RE) in patients suffering from locally advanced esophageal squamous cell carcinoma (LA-ESCC). This investigation, recently published in BMC Cancer, represents a significant leap forward in non-invasive monitoring of […]
Written by
Countdown to SLAS Europe: Minos Biosciences SAS
  1. Biotechnology

Countdown to SLAS Europe: Minos Biosciences SAS

Paris-based Minos Biosciences SAS’ (www.minos.bio) mission is to improve the understanding and treatment of complex diseases such as cancer, infectious and autoimmune diseases. As AI-powered drug discovery and therapeutic innovation holds great promise, the company’s MinoSuiteTM integrated cell analysis platform creates unprecedented multimodal datasets that will offer direct, ground-truth labels for AI training, opening  up […]
Written by
Harnessing Neddylation-Targeted Therapies to Usher in a New Era of Liver
  1. Biotechnology

Harnessing Neddylation-Targeted Therapies to Usher in a New Era of Liver

Hepatocellular carcinoma (HCC), the predominant form of primary liver cancer, continues to challenge the global healthcare landscape. Despite significant advances in oncology, the prognosis for HCC remains dismal, largely due to late diagnoses, aggressive tumor behavior, and limited effective treatment modalities. Emerging research, however, has identified a critical cellular mechanism that may redefine therapeutic strategies: […]
Written by
The past, present, and future of genome sequencing
  1. Biotechnology

The past, present, and future of genome sequencing

Newsletter Signup – Under Article / In Page “*” indicates required fields Genome sequencing is the process of determining the complete DNA sequence of an organism’s genome, a step-by-step decoding of all the genetic instructions. In humans, that means reading around 3 billion base pairs to reveal everything from disease risk and drug response to […]
Written by
A variety of cheese.
  1. Biotechnology

Whey Waste Finds New Life as Protein

Paris-based start-up Standing Ovation’s patented process converts the serums supplied by Bel into functional casein proteins. The approach offers a sustainable alternative to conventional dairy supply chains. Bel hopes that, in addition to reducing waste and creating an additional valorisation stream, it will also promote a circular economy within the industry. “Thanks to this process, […]
Written by

Good Reads

Tubulin isotypes contribute opposing properties to balance anaphase spindle morphogenesis

Faithful chromosome segregation requires proper function of the mitotic spindle, which is built from, and depends on, the coordinated regulation of many microtubules and the activities of molecular motors and MAPs. In addition, microtubules themselves are assembled from multiple variants, or isotypes of α- and β-tubulin, yet whether they mediate the activities of motors and […]
Written by

Worlwide

Tubulin isotypes contribute opposing properties to balance anaphase spindle morphogenesis

Faithful chromosome segregation requires proper function of the mitotic spindle, which is built from, and depends on, the coordinated regulation of many microtubules and the activities of molecular motors and MAPs. In addition, microtubules themselves are assembled from multiple variants, or isotypes of α- and β-tubulin, yet whether they mediate the activities of motors and […]
Written by
Leads Biolabs hits Hong Kong stock exchange in $189M IPO

Leads Biolabs hits Hong Kong stock exchange in $189M IPO

Chinese biotech company Leads Biolabs has hit the Hong Kong stock exchange, snagging $189 million through an initial public offering on the HKEX. The Nanjing-based antibody aficionado plans to use the windfall first and foremost on clinical trials, the company said in a July 24 release. About $123 million will go to clinical research, with […]
Written by

Trending

Login

Welcome to Life Science News!
"Explore the Latest Discoveries and Breakthroughs in Life Science with Life Science News!"
Read Smart, Save Time
Pick all the topics you are interested in to fill your homepage with stories you'll love.
Join our community
Registration is closed.